ArticleBMJ open2020
Bridging the gap between physical and mental illness in community pharmacy (
Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.
- Mental Health First Aid as a tool for improving mental health and well-being.The Cochrane database of systematic reviews · 2023Pooled it
- Side Effects of Psychotropic Medications Experienced by a Community Sample of People Living With Severe and Persistent Mental Illness.Health expectations : an international journal of public participation in health care and health policy · 2024Trial
- Experiences of goal planning in Australian community pharmacy settings for people experiencing mental illness: A qualitative study.Health expectations : an international journal of public participation in health care and health policy · 2023Trial
- Exploratory analysis of pharmacist involvement in motivational interviewing intervention for patients with prescription opioid misuse behaviors.JAPhA practice innovations · 2026Article
- Community pharmacists' views and experiences of delivering in-pharmacy medication reviews for people living with severe and persistent mental illness: a qualitative study.International journal of clinical pharmacy · 2024Article
- Is the long-term poor prognosis of acute myocardial infarction in patients with mental illness mediated through their poor adherence with recommended healthcare?European journal of public health · 2024Article
- Are SMART goals fit-for-purpose? Goal planning with mental health service-users in Australian community pharmacies.International journal for quality in health care : journal of the International Society for Quality in Health Care · 2024Article
- Community Pharmacists' Role in Reducing the Incidence of Cardiometabolic Adverse Drug Events in Schizophrenia: Insights from Mental Health Professionals.Medicina (Kaunas, Lithuania) · 2023Article
- Medication-related problems identified by community pharmacists: a descriptive case study of two Australian populations.Journal of pharmaceutical policy and practice · 2023Article
- Perinatal depression screening in community pharmacy: Exploring pharmacists' roles, training and resource needs using content analysis.International journal of clinical pharmacy · 2023Article
- Psychological distress in community-dwelling individuals living with severe and persistent mental illness.The International journal of social psychiatry · 2023Article
- Mental Health First Aid crisis role-plays between pharmacists and simulated patients with lived experience: a thematic analysis of debrief.Social psychiatry and psychiatric epidemiology · 2023Article
- Pharmacist Administration of Long-Acting Injectable Antipsychotics to Community-Dwelling Patients: A Scoping Review.Pharmacy (Basel, Switzerland) · 2023Article
- Mental health: "it is a subject where most pharmacists [or pharmacy] students have no more knowledge than the general public".Journal of pharmaceutical policy and practice · 2023Article
- Psychotropic medication use in people living with severe and persistent mental illness in the Australian community: a cross-sectional study.BMC psychiatry · 2022Article
- UK and Ireland survey of MPharm student and staff experiences of mental health curricula, with a focus on Mental Health First Aid.Journal of pharmaceutical policy and practice · 2021Article
- Pharmacists' roles in mental healthcare: Past, present and future.Pharmacy practiceArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThere is a significant life expectancy gap attributable to physical comorbidities for people living with severe and persistent mental illness (SPMI) compared with the general population. Medications are a major treatment for SPMI management and physical illnesses, hence pharmacists are well positioned to support mental healthcare and comorbidities. The randomised controlled trial (RCT) aim is to evaluate effectiveness of an individualised, pharmacist led, support service for people experiencing SPMI focusing on medication adherence and physical comorbidity management, compared with standard care (a medication-management service; MedsCheck). METHODS AND ANALYSIS: ETHICS AND DISSEMINATION: The protocol and pharmacist training programme received Griffith University Human Research Ethics Committee approval (HREC/2019/473 and HREC/2019/493 respectively). Results will be published in peer-reviewed journals and available at the Sixth Community Pharmacy Agreement website (http://6cpa.com.au/about-6cpa/). TRIAL REGISTRATION NUMBER: ANZCTR12620000577910.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.